טוען...
Plasma marinobufagenin immunoreactivity in patients with chronic kidney disease: a case control study
Experimental data have shown increased plasma levels of marinobufagenin in kidney failure. In this case-controlled retrospective analysis, we evaluated plasma marinobufagenin immunoreactivity in hemodialysis patients compared with subjects with normal kidney function. Sixty-eight adult hemodialysis...
שמור ב:
| הוצא לאור ב: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Physiological Society
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172577/ https://ncbi.nlm.nih.gov/pubmed/30043626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00046.2018 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|